GlaxoSmithKline PLC's ticker is and the CUSIP is G3910J112.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $216,000 | -72.6% | 12,165 | -71.7% | 0.00% | -95.5% |
| Q4 2020 | $789,000 | -79.4% | 43,033 | -79.0% | 0.04% | -80.2% |
| Q3 2020 | $3,831,000 | -25.8% | 204,455 | -19.7% | 0.22% | -23.4% |
| Q2 2020 | $5,161,000 | +1.1% | 254,505 | -6.1% | 0.29% | -1.4% |
| Q1 2020 | $5,105,000 | -7.2% | 271,135 | +16.1% | 0.29% | +36.1% |
| Q4 2019 | $5,499,000 | +12.2% | 233,450 | +2.2% | 0.22% | +9.6% |
| Q3 2019 | $4,899,000 | +16.3% | 228,370 | +8.5% | 0.20% | +20.1% |
| Q2 2019 | $4,213,000 | -13.9% | 210,440 | -10.5% | 0.16% | -15.0% |
| Q1 2019 | $4,891,000 | -14.3% | 235,230 | -21.7% | 0.19% | -21.5% |
| Q4 2018 | $5,710,000 | -22.3% | 300,230 | -18.1% | 0.25% | -9.2% |
| Q3 2018 | $7,347,000 | -0.2% | 366,780 | +0.6% | 0.27% | -2.5% |
| Q2 2018 | $7,360,000 | +0.2% | 364,530 | -2.9% | 0.28% | +6.9% |
| Q1 2018 | $7,344,000 | +158.0% | 375,540 | +135.8% | 0.26% | +165.3% |
| Q4 2017 | $2,847,000 | -29.5% | 159,280 | -21.3% | 0.10% | -30.5% |
| Q3 2017 | $4,037,000 | -31.3% | 202,425 | -26.6% | 0.14% | -31.6% |
| Q2 2017 | $5,873,000 | +2.4% | 275,720 | 0.0% | 0.21% | +2.5% |
| Q1 2017 | $5,733,000 | -2.7% | 275,720 | -9.9% | 0.20% | -1.0% |
| Q4 2016 | $5,891,000 | -16.6% | 306,100 | -7.7% | 0.20% | -15.1% |
| Q3 2016 | $7,067,000 | -0.3% | 331,805 | 0.0% | 0.24% | -4.4% |
| Q2 2016 | $7,087,000 | -5.5% | 331,805 | -10.2% | 0.25% | -5.7% |
| Q1 2016 | $7,497,000 | +0.3% | 369,400 | 0.0% | 0.26% | +5.2% |
| Q4 2015 | $7,475,000 | +40.2% | 369,400 | +32.7% | 0.25% | +34.8% |
| Q3 2015 | $5,332,000 | -27.4% | 278,400 | -21.2% | 0.19% | -20.4% |
| Q2 2015 | $7,344,000 | -35.8% | 353,400 | -29.1% | 0.24% | -26.8% |
| Q1 2015 | $11,438,000 | +7.0% | 498,400 | 0.0% | 0.32% | +10.3% |
| Q4 2014 | $10,693,000 | -6.3% | 498,400 | 0.0% | 0.29% | -7.0% |
| Q3 2014 | $11,417,000 | -22.5% | 498,400 | -9.6% | 0.31% | -18.3% |
| Q2 2014 | $14,738,000 | -6.4% | 551,100 | -7.1% | 0.38% | -10.1% |
| Q1 2014 | $15,738,000 | +49.0% | 593,150 | +49.9% | 0.43% | +53.2% |
| Q4 2013 | $10,563,000 | +5.8% | 395,750 | 0.0% | 0.28% | -1.8% |
| Q3 2013 | $9,982,000 | +0.9% | 395,750 | 0.0% | 0.28% | -5.7% |
| Q2 2013 | $9,892,000 | – | 395,750 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|